In a new two year clinical trial conducted by the University of Miami, researchers will attempt to treat deep second degree burn victims with mesenchymal stem cells [MSCs] as a potential alternative to skin grafts. The team, led by Dr. Evangelos Badiavas, will first cover the wounds in protective dressing, and then inject the MSCs under the dressing and into the wounds to spur the regeneration of the inner and outer layers of skin.
Severe burns currently account for 450,000 emergency room treatments annually, as well as 15-20% of combat injuries to military veterans. But despite a high demand to eliminate painful and taxing skin graft surgeries, they are currently the only option for reconstruction. While Dr. Badiavas’ stem cell therapy is in its initial assessment phase, early indications point to possible MSC treatments that may provide a more comfortable and efficient method to regenerate healthy skin tissue, resulting in better outcomes for patients.
As regenerative engineering progresses, we believe the best stem cells to use in emerging treatments will be the patient’s own [autologous stem cells] as this negates the need to find a suitable donor and eliminates the chances of rejection of the transplanted tissue. To learn more about banking your own valuable stem cells to insure your family’s future health, visit StemSave or call 877-783-6728 (877-StemSave) today.
To view the full article, click here.
The Future of Regenerative Medicine is Now™